Patent · US Active

LHRH—antagonists in the treatment of fertility disorders

US9107871B2 · kind B2 · utility

0Cited by

4References

1Claims

0Family size

Assignee

ZENTARIS IVP GMBH · DE

Inventors

Philippe Bouchard · Paris, FR
Rene Frydman · Paris, FR
Paul Devroey · Aalst, BE
Klaus Diedrich · Gladbeck, DE
Jurgen Engel · Alzenau, DE

Key dates

Filing date	Nov 8, 2010
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Apr 25, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12M21/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for obtaining the production of a fertilizable oocyte within a program of assisted reproduction techniques comprising normal follicular growth and development to proceed in the absence of stimulation by an exogenous gonadotropin, followed by administering an amount of an LHRH antagonist in a dosage regimen that prevents a premature LH surge while maintaining FSH secretion at a natural level and individual estrogen development is not affected.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.